<DOC>
	<DOCNO>NCT00538798</DOCNO>
	<brief_summary>The metabotropic glutamate subtype five ( mGluR5 ) receptor protein find brain target excitatory chemical messenger glutimate . The purpose protocol measure mGluR5 receptor brain use positron emission tomography ( PET ) research drug call [ 18F ] SP203 .</brief_summary>
	<brief_title>PET Imaging Brain mGluR5 Receptors Using 18FSP203</brief_title>
	<detailed_description>Metabotropic glutamate receptor G-protein couple receptor respond glutamate activate protein inside nerve cell affect cell metabolism , thereby fine-tuning signal send cell maintain balance neuronal activity . Metabotropic Glutamate receptor ( mGluR5 ) Group I receptors localized post-synaptically find several region brain include striatum , hippocampus , amygdala , cortex . Activation mGluR5 stimulate phospholipase C , result phosphoinositide hydrolysis increase intracellular Ca2+ level . Several potent antagonist mGluR5 develop , include 6 methyl-2- ( phenylethynyl ) pyridine ( MPEP ) 3- [ ( 2-methyl-1,3-thiazol-4yl ) ethynyl ] pyridine ( MTEP ) however , simple derivative MPEP MTEP proven useful vivo imaging . In present protocol , use new PET ligand [ ( 18 ) F ] SP203 two reason : Part 1 . ) perform kinetic brain image quantify mGluR5 bind parameter brain determine reliability reproducibility measure 15 healthy control Part 2 . ) tracer prove successful part 1 , plan estimate radiation-absorbed dos [ ( 18 ) F ] SP203 healthy human subject perform whole body image . We also use another new ligand , [ 11C ] SP203 , structure [ ( 18 ) F ] SP203 label ( 11 ) C instead ( 18 ) F. Part 3 ) purpose part 1 [ ( 11 ) C ] SP203 instead [ ( 18 ) F ] SP203 . Part 4 ) [ ( 11 ) C ] SP203 prove successful part 3 , plan estimate radiation absorb dos [ ( 11 ) C ] SP203 healthy human subject . At moment , plan perform additional scan [ ( 18 ) F ] SP203 current protocol . All future subject participate scan [ ( 11 ) C ] SP203 . Additionally , Part 5 ) measure difference [ ( 18 ) F ] SP203 concentration artery vein without PET scan assess whether venous blood valid less invasive substitute arterial blood . In [ ( 18 ) F ] SP203 scan perform current protocol , compare [ ( 18 ) F ] SP203 level radial artery antecubital vein observe 30 % - 60 % low level vein . We plan test whether sample vein hand / warming make [ ( 18 ) F ] SP203 level vein similar artery . Successful development PET ligand image mGluR5 strong impact clinical management brain disorder disruption glutamatergic transmission schizophrenia , anxiety , neurodegenerative disorder include Alzheimer Parkinson disease .</detailed_description>
	<criteria>INCLUSION CRITERIA : Healthy control subject age 18 65 year , history/physical exam , ECG , laboratory test within one year PET scan within normal limit . EXCLUSION CRITERIA : 1 . Current psychiatric illness , substance abuse severe systemic disease base history physical exam . 2 . Laboratory test clinically significant abnormality . 3 . Prior participation research protocols clinical care last year radiation exposure would exceed annual limit . 4 . Pregnancy breast feed . 5 . Claustrophobia . ( part 1 3 ) 6 . Presence ferromagnetic metal body heart pacemaker . ( part 1 3 ) 7 . Positive HIV test . 8 . Consumed alcohol within 48 hour PET scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 17, 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Binding Potential</keyword>
	<keyword>Glutamate</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Metabolic Glutamate Receptors</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>